P04626 (ERBB2_HUMAN) Homo sapiens (Human)

Receptor tyrosine-protein kinase erbB-2 UniProtKBInterProSTRINGInteractive Modelling

1255 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6); 1 identical sequence: Homo sapiens: X5DNK3

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex
8q6j
 Heteromer
23-646
2×NAG; 3×NAG;
Assess
Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex
8pwh
 Heteromer
23-646
2×NAG; 3×NAG;
Assess
Structure of Zanidatamab bound to HER2
8ffj
 Heteromer
23-644
Assess
Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex
6oge
 Heteromer
P01834; P0DOX5; Q6GMX6; 		23-644
1×NAG; 5×NAG;
Assess
Crystallographic trimer of HER2 extracellular regions in complex with tryptophan-rich antibody frag…
3n85
 Heteromer
23-642
3×NAG; 3×NAG; 3×CL; 48×SO4;
Assess
HuA21-scFv in complex with the extracellular domain(ECD) of HER2
6j71
 Heteromer
22-639
1×NAG; 1×BMA;
Assess
Crystal structure of extracellular domain of human HER2 complexed with Herceptin Fab
1n8z
 Heteromer
23-629
2×NAG; 1×SO4;
Assess
Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain
6bgt
 Heteromer
P0DOX5; Q7Z3Y4; 		23-629
1×NAG;
Assess
Dual specific bH1 Fab in complex with the extracellular domain of HER2/ErbB-2
3be1
 Heteromer
23-629
2×NAG; 1×MES;
Assess
Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain bound to Trastuzumab Fab
7mn8
 Heteromer
P21860; Q02297; 		24-629
2×NAG; 1×NAG; 5×NAG;
Assess
Structure of the HER2/HER4/BTC Heterodimer Extracellular Domain
8u4k
 Heteromer
P35070; Q15303; 		24-629
2×NAG; 1×NAG; 5×NAG; 2×NAG; 3×NAG;
Assess
Structure of the HER2/HER4/NRG1b Heterodimer Extracellular Domain
8u4l
 Heteromer
Q02297; Q15303; 		24-629
2×NAG; 1×NAG; 5×NAG; 2×NAG; 3×NAG;
Assess
HER2 extracelluar region with affinity matured 3-helix affibody ZHER2:342
3mzw
 Heteromer
P38507; 		23-600
1×NAG; 2×NAG;
Assess
Crystal structure of extracellular domain of HER2 in complex with Fcab STAB19
5k33
 Heteromer
P01857; 		23-598
2×NAG; 2×NAG; 2×GOL; 4×NAG;
Assess
The EREG-bound EGFR/HER2 ectodomain complex
8hgp
 Heteromer
O14944; P00533; 		24-599
1×NAG; 1×NAG; 2×NAG;
Assess
The EGF-bound EGFR/HER2 ectodomain complex
8hgo
 Heteromer
P00533; P01133; 		24-599
1×NAG; 1×NAG; 2×NAG;
Assess
39S Fab bound to HER2 ecd
6att
 Heteromer
23-597
2×NAG; 1×NAG;
Assess
Crystal structure of extracellular domain of HER2 in complex with Fcab H10-03-6
5kwg
 Heteromer
P01857; 		23-597
Assess
Crystal structure of a HER2-Nb complex
5my6
 Heteromer
24-597
1×NAG; 1×NAG; 2×GOL;
Assess
Molecular Architecture of the ErbB2 Extracellular Domain Homodimer
3wlw
 Heteromer
23-586
1×NAG;
Assess
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
1s78
 Heteromer
Q7Z3Y4; 		23-586
2×NAG; 1×NAG;
Assess
Structure of HER2 with an Fab
3wsq
 Heteromer
23-586
Assess
HER2 in complex with Fab MF3958
5o4g
 Heteromer
23-564
1×NAG; 1×NAG; 1×NAG;
Assess
NM-02 in complex with HER2-ECD
7qvk
 Heteromer
24-541
1×NAG; 1×NAG;
Assess
Crystal structure of anti-HER2 antibody H2Mab-119 in complex with HER2 domain I
8jyr
 Heteromer
23-215
1×NAG;
Assess
Crystal structure of the single-chain Fv (scFv) fragment of an anti-ErbB2 antibody chA21 in complex…
3h3b
 Heteromer
23-214
Assess
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t…
4hrl
 Heteromer
24-213
Assess
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t…
4hrm
 Heteromer
24-213
Assess
Crystal structure of HER2 Domain IV and Rb-H2
6lbx
 Heteromer
531-601
1×NAG;
Assess
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t…
4hrn
 Heteromer
531-601
Assess
Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase Act…
2ks1
 Heteromer
P00533; 		641-684
Assess
Solution structure of the human Grb7-SH2 domain in complex with a 10 amino acid peptide pY1139
1mw4
 Heteromer
Q14451; 		1135-1144
Assess
Water refined solution structure of the human Grb7-SH2 domain in complex with the 10 amino acid pep…
2l4k
 Heteromer
Q14451; 		1135-1144
Assess
The Structure of ERBIN PDZ domain bound to the Carboxy-terminal tail of the ErbB2 Receptor
1mfg
 Heteromer
Q96RT1; 		1247-1255
Assess
POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTE…
1qr1
 Heteromer
P04439; P61769; 		654-662
Assess
PTPN18 in complex with HER2-pY1248 phosphor-peptides
4gfu
 Heteromer
Q99952; 		1246-1252
Assess
Phospholipase C gamma-1 C-terminal SH2 domain bound to a phosphopeptide derived from the receptor t…
5tqs
 Heteromer
P08487; 		1220-1225
Assess
Structural basis of PTPN18 fingerprint on distinct HER2 tyrosine phosphorylation sites
4nnd
 Heteromer
Q99952; 		1109-1114
Assess
The Structure of ERBIN PDZ domain bound to the Carboxy-terminal tail of the ErbB2 Receptor
1mfl
 Heteromer
Q96RT1; 		1251-1255
Assess
Spatial structure of HER2/ErbB2 dimeric transmembrane domain in the presence of cytoplasmic juxtame…
2n2a
homo-2-mer644-700
Assess
ErbB2 transmembrane segment dimer spatial structure
2jwa
homo-2-mer641-684
Assess
NMR spatial structure of HER2 TM domain dimer in DPC micelles.
5ob4
homo-2-mer641-684
Assess
Crystal structure of ErbB2 domains 1-3
2a91
monomer22-530
1×NAG; 2×NAG;
Assess
HER2 Kinase Domain Complexed with TAK-285
3rcd
monomer713-1022
1×03P;
Assess
HER2 in complex with JBJ-08-178-01
7jxh
monomer707-996
1×VOY;
Assess
Crystal Structure of the Kinase domain of Human HER2 (erbB2).
3pp0
monomer706-993
1×03Q;
Assess
HER2 IN COMPLEX WITH A COVALENT INHIBITOR
7pcd
monomer710-991
1×70I;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7mn5.1.Cmonomer0.7924-629
99.90
Assess
3bbt.1.Amonomer0.69710-999
1×FMM;72.90
Assess
7syd.1.Cmonomer0.6824-644
53.11
Assess

10 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23pp0.2.Amonomer0.7596-399
1×03Q;98.18
Assess
Isoform 27mn8.1.Cmonomer0.623-19
99.76
Assess
Isoform 34riy.2.Bmonomer0.7710-305
1×ADP;77.94
Assess
Isoform 47mn5.1.Cmonomer0.799-614
99.31
Assess
Isoform 43bbt.1.Amonomer0.69695-984
1×FMM;72.81
Assess
Isoform 47syd.1.Cmonomer0.685-629
52.92
Assess
Isoform 57mn5.1.Cmonomer0.791-599
99.90
Assess
Isoform 53bbt.1.Amonomer0.69680-969
1×FMM;72.90
Assess
Isoform 57syd.1.Cmonomer0.682-614
53.13
Assess
Isoform 67mn5.1.Cmonomer0.8124-629
94.18
Assess